Editorial
Establishing Rules of the Road for Pharmaceutical Representatives
Being up-front can help prevent back-door tactics.
| What do you think? |
|
The views and opinions expressed in the editorials published in do not necessarily represent those of or our publisher, the American Academy of Family Physicians. We recognize that your point of view may differ from the author's, and we encourage you to share it. Please send your comments to via e-mail at fpmedit@aafp.org or overland to 11400 Tomahawk Creek Parkway, Leawood, Kansas 66211-2672. |
Interactions with pharmaceutical representatives often evoke mixed feelings for many physicians. On one hand, reps can provide us with useful information on new drugs and new study results, indications, contraindications and recalls. They also provide samples that benefit our patients. On the other hand, they may take up more time than we have available, and they may employ high-pressure sales techniques. This conflict had been building at my office to the point where I was ready to stop seeing them altogether.
Although I couldn't speak for my partners, I wrote the reps an open letter and posted multiple copies in my sample and break rooms. So far the response has been better than imagined. Many reps have told me they appreciate knowing my expectations. If the letter offended any, they've kept it a secret. Some have found it hard to leave all of their high-pressure techniques behind, but our interactions have improved overall.
Feel free to adapt the letter for your own use. From
the FPM Web site at
http://www.aafp.org/fpm/20050300/10esta.html, you can easily download
a version that is suitable for printing (PDF file, 2
pages/21 KB) or a Word file (2 pages/ 27 KB) that can
be modified according to your preferences. (More information on
PDF files or downloading
files.)
![]()
|
Dr. Evans practices with ProMedica Physicians Group in Perrysburg, Ohio. Conflicts of interest: none reported.
|
Copyright © 2005 by the
American Academy of Family Physicians. |
MEDLINE:
• Citation
RELATED TOPICS:
Professional relations (53)
Pharmaceutical industry (27)
Commerce (5)
Drug Industry (3)








